Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Correction of Hemoglobin and Outcomes In Renal Insufficiency

NCT00211120 is registered in ClinicalTrials.gov with Johnson & Johnson Pharmaceutical Research & Development, L.L.C. as lead sponsor.

NCT NCT00211120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00211120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Correction of Hemoglobin and Outcomes In Renal Insufficiency
Lead sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Phase
Phase 4
Overall status
Terminated
Start date
March 31, 2002
Completion date
August 31, 2005
Enrollment
1,432 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anemia